- Home
- ICCM vs HBIO Comparison
ICCM vs HBIO Comparison
Compare ICCM & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCM
- HBIO
- Stock Information
- Founded
- ICCM 2006
- HBIO 1901
- Country
- ICCM Israel
- HBIO United States
- Employees
- ICCM N/A
- HBIO N/A
- Industry
- ICCM
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- ICCM
- HBIO Industrials
- Exchange
- ICCM Nasdaq
- HBIO Nasdaq
- Market Cap
- ICCM 70.1M
- HBIO 61.2M
- IPO Year
- ICCM N/A
- HBIO 2000
- Fundamental
- Price
- ICCM $1.23
- HBIO $0.47
- Analyst Decision
- ICCM Strong Buy
- HBIO Buy
- Analyst Count
- ICCM 1
- HBIO 1
- Target Price
- ICCM $2.50
- HBIO $4.50
- AVG Volume (30 Days)
- ICCM 339.7K
- HBIO 387.1K
- Earning Date
- ICCM 03-27-2025
- HBIO 03-12-2025
- Dividend Yield
- ICCM N/A
- HBIO N/A
- EPS Growth
- ICCM N/A
- HBIO N/A
- EPS
- ICCM N/A
- HBIO N/A
- Revenue
- ICCM $3,291,000.00
- HBIO $94,135,000.00
- Revenue This Year
- ICCM $75.63
- HBIO N/A
- Revenue Next Year
- ICCM $69.36
- HBIO $7.97
- P/E Ratio
- ICCM N/A
- HBIO N/A
- Revenue Growth
- ICCM 1.92
- HBIO N/A
- 52 Week Low
- ICCM $0.48
- HBIO $0.45
- 52 Week High
- ICCM $1.66
- HBIO $4.70
- Technical
- Relative Strength Index (RSI)
- ICCM 46.09
- HBIO 19.97
- Support Level
- ICCM $1.04
- HBIO $0.56
- Resistance Level
- ICCM $1.25
- HBIO $0.67
- Average True Range (ATR)
- ICCM 0.10
- HBIO 0.06
- MACD
- ICCM -0.01
- HBIO 0.02
- Stochastic Oscillator
- ICCM 38.78
- HBIO 8.36
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.